Centrosome-associated regulators of the G2/M checkpoint as targets for cancer therapy

Yingmei Wang, Ping Ji, Jinsong Liu, Russell R. Broaddus, Fengxia Xue, Wei Zhang

Research output: Contribution to journalReview articlepeer-review

138 Scopus citations


In eukaryotic cells, control mechanisms have developed that restrain cell-cycle transitions in response to stress. These regulatory pathways are termed cell-cycle checkpoints. The G2/M checkpoint prevents cells from entering mitosis when DNA is damaged in order to afford these cells an opportunity to repair the damaged DNA before propagating genetic defects to the daughter cells. If the damage is irreparable, checkpoint signaling might activate pathways that lead to apoptosis. Since alteration of cell-cycle control is a hallmark of tumorigenesis, cell-cycle regulators represent potential targets for therapy. The centrosome has recently come into focus as a critical cellular organelle that integrates G2/M checkpoint control and repairs signals in response to DNA damage. A growing number of G2/M checkpoint regulators have been found in the centrosome, suggesting that centrosome has an important role in G2/M checkpoint function. In this review, we discuss centrosome-associated regulators of the G2/M checkpoint, the dysregulation of this checkpoint in cancer, and potential candidate targets for cancer therapy.

Original languageEnglish (US)
Article number8
JournalMolecular Cancer
StatePublished - Feb 13 2009
Externally publishedYes

ASJC Scopus subject areas

  • Molecular Medicine
  • Oncology
  • Cancer Research


Dive into the research topics of 'Centrosome-associated regulators of the G2/M checkpoint as targets for cancer therapy'. Together they form a unique fingerprint.

Cite this